19-15192033-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000435.3(NOTCH3):​c.606A>G​(p.Ala202Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.873 in 1,613,208 control chromosomes in the GnomAD database, including 615,923 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.87 ( 57799 hom., cov: 34)
Exomes 𝑓: 0.87 ( 558124 hom. )

Consequence

NOTCH3
NM_000435.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -3.47

Publications

46 publications found
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]
NOTCH3 Gene-Disease associations (from GenCC):
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral meningocele syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myofibromatosis, infantile, 2
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 19-15192033-T-C is Benign according to our data. Variant chr19-15192033-T-C is described in ClinVar as Benign. ClinVar VariationId is 256148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.47 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH3NM_000435.3 linkc.606A>G p.Ala202Ala synonymous_variant Exon 4 of 33 ENST00000263388.7 NP_000426.2
NOTCH3XM_005259924.5 linkc.606A>G p.Ala202Ala synonymous_variant Exon 4 of 32 XP_005259981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH3ENST00000263388.7 linkc.606A>G p.Ala202Ala synonymous_variant Exon 4 of 33 1 NM_000435.3 ENSP00000263388.1
NOTCH3ENST00000601011.1 linkc.603A>G p.Ala201Ala synonymous_variant Exon 4 of 23 5 ENSP00000473138.1

Frequencies

GnomAD3 genomes
AF:
0.870
AC:
132353
AN:
152104
Hom.:
57761
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.907
Gnomad AMI
AF:
0.866
Gnomad AMR
AF:
0.763
Gnomad ASJ
AF:
0.878
Gnomad EAS
AF:
0.865
Gnomad SAS
AF:
0.834
Gnomad FIN
AF:
0.863
Gnomad MID
AF:
0.861
Gnomad NFE
AF:
0.876
Gnomad OTH
AF:
0.847
GnomAD2 exomes
AF:
0.848
AC:
212142
AN:
250060
AF XY:
0.851
show subpopulations
Gnomad AFR exome
AF:
0.909
Gnomad AMR exome
AF:
0.701
Gnomad ASJ exome
AF:
0.871
Gnomad EAS exome
AF:
0.863
Gnomad FIN exome
AF:
0.866
Gnomad NFE exome
AF:
0.879
Gnomad OTH exome
AF:
0.845
GnomAD4 exome
AF:
0.873
AC:
1275651
AN:
1460986
Hom.:
558124
Cov.:
84
AF XY:
0.872
AC XY:
633809
AN XY:
726822
show subpopulations
African (AFR)
AF:
0.908
AC:
30391
AN:
33480
American (AMR)
AF:
0.708
AC:
31627
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.872
AC:
22784
AN:
26136
East Asian (EAS)
AF:
0.880
AC:
34938
AN:
39696
South Asian (SAS)
AF:
0.841
AC:
72501
AN:
86256
European-Finnish (FIN)
AF:
0.866
AC:
45521
AN:
52558
Middle Eastern (MID)
AF:
0.825
AC:
4761
AN:
5768
European-Non Finnish (NFE)
AF:
0.882
AC:
981180
AN:
1112004
Other (OTH)
AF:
0.860
AC:
51948
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
11522
23044
34567
46089
57611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21340
42680
64020
85360
106700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.870
AC:
132443
AN:
152222
Hom.:
57799
Cov.:
34
AF XY:
0.867
AC XY:
64511
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.907
AC:
37674
AN:
41548
American (AMR)
AF:
0.763
AC:
11665
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.878
AC:
3045
AN:
3470
East Asian (EAS)
AF:
0.866
AC:
4462
AN:
5154
South Asian (SAS)
AF:
0.834
AC:
4021
AN:
4822
European-Finnish (FIN)
AF:
0.863
AC:
9153
AN:
10608
Middle Eastern (MID)
AF:
0.847
AC:
249
AN:
294
European-Non Finnish (NFE)
AF:
0.876
AC:
59601
AN:
68016
Other (OTH)
AF:
0.844
AC:
1783
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
916
1832
2749
3665
4581
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.879
Hom.:
32884
Bravo
AF:
0.865
Asia WGS
AF:
0.837
AC:
2908
AN:
3478
EpiCase
AF:
0.872
EpiControl
AF:
0.867

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 14, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lateral meningocele syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.10
DANN
Benign
0.18
PhyloP100
-3.5
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1043994; hg19: chr19-15302844; COSMIC: COSV99656519; API